312 related articles for article (PubMed ID: 34399805)
1.
Kowalski ES; Khairnar R; Gryaznov AA; Kesari V; Koroulakis A; Raghavan P; Chen W; Woodworth G; Mishra M
Radiat Oncol; 2021 Aug; 16(1):151. PubMed ID: 34399805
[TBL] [Abstract][Full Text] [Related]
2. Improved Detection of Transosseous Meningiomas Using
Kunz WG; Jungblut LM; Kazmierczak PM; Vettermann FJ; Bollenbacher A; Tonn JC; Schichor C; Rominger A; Albert NL; Bartenstein P; Reiser MF; Cyran CC
J Nucl Med; 2017 Oct; 58(10):1580-1587. PubMed ID: 28450556
[No Abstract] [Full Text] [Related]
3.
Perlow HK; Siedow M; Gokun Y; McElroy J; Matsui J; Zoller W; Beyer S; Arnett A; Blakaj D; Boulter D; Fritz J; Miller E; Raval R; Kleefisch C; Bovi J; Palmer JD
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(4):859-865. PubMed ID: 35460804
[TBL] [Abstract][Full Text] [Related]
4. The significance of incidental brain uptake on 68Ga-DOTATATE PET-CT in neuroendocrine tumour patients.
Cleary JO; Yeung J; McMeekin H; Wilhelm T; Wagner T
Nucl Med Commun; 2016 Nov; 37(11):1197-205. PubMed ID: 27399848
[TBL] [Abstract][Full Text] [Related]
5. Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI.
Afshar-Oromieh A; Giesel FL; Linhart HG; Haberkorn U; Haufe S; Combs SE; Podlesek D; Eisenhut M; Kratochwil C
Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1409-15. PubMed ID: 22669255
[TBL] [Abstract][Full Text] [Related]
6. Recurrence pattern analysis after [
Zollner B; Ganswindt U; Maihöfer C; Corradini S; Albert NL; Schichor C; Belka C; Niyazi M
Radiat Oncol; 2018 Jun; 13(1):110. PubMed ID: 29898747
[TBL] [Abstract][Full Text] [Related]
7. Influence of
Stade F; Dittmar JO; Jäkel O; Kratochwil C; Haberkorn U; Debus J; Combs SE
Radiat Oncol; 2018 Apr; 13(1):58. PubMed ID: 29606149
[TBL] [Abstract][Full Text] [Related]
8. A Prospective Registry Study of
Perlow HK; Nalin AP; Handley D; Gokun Y; Blakaj DM; Beyer SJ; Thomas EM; Raval RR; Boulter D; Kleefisch C; Bovi J; Chen WC; Braunstein SE; Raleigh DR; Knisely JPS; Ivanidze J; Palmer JD
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(4):979-985. PubMed ID: 37871886
[TBL] [Abstract][Full Text] [Related]
9. [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning.
Gehler B; Paulsen F; Oksüz MO; Hauser TK; Eschmann SM; Bares R; Pfannenberg C; Bamberg M; Bartenstein P; Belka C; Ganswindt U
Radiat Oncol; 2009 Nov; 4():56. PubMed ID: 19922642
[TBL] [Abstract][Full Text] [Related]
10. 68Ga-DOTA-peptide PET/CT for radiotherapy planning and evaluating treatment response in the management of meningiomas.
Usmani S; Jain A; Hashmi SF; Mula-Hussain L; Riyami KA; Abubakar S; Shamim MS
J Pak Med Assoc; 2023 Jun; 73(6):1340-1343. PubMed ID: 37427649
[TBL] [Abstract][Full Text] [Related]
11. Using 68 Ga-DOTATATE PET for Postoperative Radiosurgery and Radiotherapy Planning in Patients With Meningioma: A Case Series.
Hintz EB; Park DJ; Ma D; Viswanatha SD; Rini JN; Schulder M; Goenka A
Neurosurgery; 2023 Jul; 93(1):95-101. PubMed ID: 36722951
[TBL] [Abstract][Full Text] [Related]
12. Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas.
Ivanidze J; Roytman M; Lin E; Magge RS; Pisapia DJ; Liechty B; Karakatsanis N; Ramakrishna R; Knisely J; Schwartz TH; Osborne JR; Pannullo SC
J Neuroimaging; 2019 Sep; 29(5):650-656. PubMed ID: 31107591
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous
Maclean J; Fersht N; Sullivan K; Kayani I; Bomanji J; Dickson J; O'Meara C; Short S
Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):448-458. PubMed ID: 28433399
[TBL] [Abstract][Full Text] [Related]
14. The trends and significance of SSTR PET/CT added to MRI in follow-up imaging of low-grade meningioma treated with fractionated proton therapy.
Lütgendorf-Caucig C; Pelak M; Flechl B; Georg P; Fossati P; Stock M; Traub-Weidinger T; Marosi C; Haberler C; Zechmeister-Machhart G; Hermsmeyer L; Hug E; Staudenherz A
Strahlenther Onkol; 2023 Apr; 199(4):396-403. PubMed ID: 36260109
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness Analysis of
Rodriguez J; Martinez G; Mahase S; Roytman M; Haghdel A; Kim S; Madera G; Magge R; Pan P; Ramakrishna R; Schwartz TH; Pannullo SC; Osborne JR; Lin E; Knisely JPS; Sanelli PC; Ivanidze J
AJNR Am J Neuroradiol; 2023 Jul; 44(7):783-791. PubMed ID: 37290818
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience.
Thorwarth D; Henke G; Müller AC; Reimold M; Beyer T; Boss A; Kolb A; Pichler B; Pfannenberg C
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):277-83. PubMed ID: 21300465
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET.
Combs SE; Welzel T; Habermehl D; Rieken S; Dittmar JO; Kessel K; Jäkel O; Haberkorn U; Debus J
Acta Oncol; 2013 Apr; 52(3):514-20. PubMed ID: 23402336
[TBL] [Abstract][Full Text] [Related]
18. Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue.
Rachinger W; Stoecklein VM; Terpolilli NA; Haug AR; Ertl L; Pöschl J; Schüller U; Schichor C; Thon N; Tonn JC
J Nucl Med; 2015 Mar; 56(3):347-53. PubMed ID: 25635133
[TBL] [Abstract][Full Text] [Related]
19. Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.
Boursier C; Zaragori T; Bros M; Bordonne M; Melki S; Taillandier L; Blonski M; Roch V; Marie PY; Karcher G; Imbert L; Verger A
Eur Radiol; 2023 Oct; 33(10):7089-7098. PubMed ID: 37148355
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of somatostatin receptor positron emission tomography imaging biomarkers for characterization of meningioma among incidental central nervous system lesions.
Ensign SF; Agarwal M; Klanderman M; Badawy M; Halfdanarson TR; Johnson DR; Sonbol MB; Kendi AT
Nucl Med Commun; 2023 Jul; 44(7):663-670. PubMed ID: 37158225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
